P-1085. An Opportunity for Stewardship: Idle Peripheral Venous Catheters

Background Peripheral intravenous catheters (PIVC) are among the most common medical intervention for hospitalized patients. While PIVC can provide life-saving treatments, PIVC are also a major source of complications such as infiltration, occlusion, leaking, pain, dislodgement, and bacteremia, particularly due to Staphylococcus aureus. Both the Infusion Nurses Society (INS) and the Centers for Disease Control and Prevention state that PIVC that are no longer in use should be removed, with INS specifically stating that a catheter that has not used for more than 24 hours should be removed. Despite the guidance to remove PIVC that are unused, prevalence studies demonstrate that approximately 14% of all PIVC have not been used in the prior 24 hours. These “idle PIVC” contribute to avoidable morbidity and mortality. The goal of this study is to assess the opportunity for harm reduction at our institution by evaluating the prevalence of idle PIVC and the incidence of S. aureus bacteremia attributed to PIVC.Figure 1.Peripheral intravenous catheter days in hospitalized patients, 2024 Methods This is a retrospective cohort study at a 500-bed academic safety net hospital in Denver, CO. The study dates are 1/1/24 through 12/31/24. All hospitalized patients were eligible for inclusion. PIVC were considered idle if they had not been used for at least 24 hours. Hospital onset S. aureus bacteremia was defined as those presenting on hospital day 4 or greater, with the day of admission being hospital day 1. A hospital-onset S. aureus bacteremia case was considered secondary to PVC if there was erythema, induration, or purulent drainage at the site of a PIVC that was currently in place or had been removed in the prior 7 days. Results During the study period, there was a mean of 18,071 total PIVC days per month. The proportion of idle PIVC days ranged from 11.3% to 13.2% with a mean of 12.2% (Figure 1). There were 7 cases of hospital onset S. aureus bacteremia (5 MSSA, 2 MRSA) attributed to PIVC during the study period. The rate of PIVC-related S. aureus bacteremia was 0.4 cases per 1000 PIVC days. Conclusion Idle PIVC are prevalent in our institution. There is substantial opportunity to decrease the prevalence of idle PIVC. A reduction in idle PIVC could lead to fewer hospital onset S. aureus bacteremia cases. Disclosures All Authors: No reported disclosures